Patient perspectives on incretin‐based weight loss medications and relationship with demographic factors

• Main Authors: Megan A. McVay (Author), Wendy S. Moore (Author), Francesca L. Wilkins (Author), Jalen R. Jackson (Author), Michael D. Robinson (Author)
• Format: Knjiga
• Izdano: Wiley, 2024-08-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

Abstract Objective Treatment of obesity has been transformed by the recent approval of incretin‐based therapies for weight loss (e.g., glucagon‐like peptide 1 agonist semaglutide), but little is known about patient perspectives on these medications. Methods Between December 2023 and March 2024, heal...